Virtu Financial’s XORTX Therapeutics XRTX Stock Holding History

Virtu Financial’s Portfolio XRTX Stock Details XRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-32	Closed	-$6K	–	2112
2023 Q1	$6K	Buy	+32	New	+$8.04K	﹤0.01%	1387
2022 Q2	–	Sell	-30	Closed	-$24K	–	2144
2022 Q1	$24K	Buy	+30	New	+$19.8K	﹤0.01%	1269

Other funds holding XRTX

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial's XRTX Position: Q2 2023 in Review

Virtu Financial sold out of XORTX Therapeutics (XRTX) in Q2 2023, closing a stake of 32 shares — an estimated $6K sold.

Virtu Financial first reported a position in XRTX in Q1 2022 and held it in 2 quarters. The position peaked at $24K in Q1 2022. 3 funds tracked by Wall St. Rank hold XRTX as of Q2 2023.

Virtu Financial reported no remaining XORTX Therapeutics position as of Q2 2023 after selling out during the quarter.
Virtu Financial sold 32 XORTX Therapeutics shares in Q2 2023, an estimated $6K.
Virtu Financial first reported a position in XORTX Therapeutics in Q1 2022 and held it in 2 quarters.
Virtu Financial's XORTX Therapeutics position peaked at $24K in Q1 2022.
3 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.